MedTrace Logo

Serum Bupivacaine Concentration Levels After Intermittent Bolus Injections Via Erector Spinae Plane Peripheral Catheter

NCT05038956 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2025-02-13

No results posted yet for this study

Summary

The purpose of this study is to evaluate the serum bupivacaine concentrations over time after 0.125% bupivacaine is deposited every 6 hours in the erector spinae plane in patients who undergo unilateral VATS.

Conditions

  • Video-assisted Thoracic Surgery (VATS)

Sponsors & Collaborators

Principal Investigators

  • Kasinda Goodwin, MD · University of Utah

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-01
Primary Completion
2025-10-01
Completion
2025-11-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05038956 on ClinicalTrials.gov